Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, July 22 2014 5:17am ET - U.S. Markets open in 4 hours and 13 minutes.
Industry Center - Drug Manufacturers - Other
Industry Center > Drug Manufacturers - Other > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Other News
Latest News
Monday, Jul 21, 2014
·Allergan EPS Growth, Job Cuts Counter Valeant
Investor's Business Daily, Inc. - Mon 6:30 pm ET
·Dealpolitik: Valeant Calls Foul on Allergan's Withering Attacks
at The Wall Street Journal Online - Mon 6:08 pm ET
·Allergan to cut 1,500 employees in restructuring
AP - Mon 5:14 pm ET
·Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar?
at Seeking Alpha - Mon 4:38 pm ET
·[video] What to Expect from Ackman’s Herbalife Presentation
at Bloomberg - Mon 4:25 pm ET
·Greenberg: Allergan's Dilemma
at - Mon 4:21 pm ET
·Under-Promising and Over-Delivering: Why Allergan Is a Buy
- Mon 4:01 pm ET
·Allergan to cut 13 percent of jobs in fight against Valeant
Reuters - Mon 3:35 pm ET
·How Much Will Those Allergan Cost Cuts Really Help? Read Here
at The Wall Street Journal Online - Mon 3:28 pm ET
·Ackman says not hedged in position in Allergan
- Mon 2:54 pm ET
·What The SEC Should Ask Valeant; Allergan Investors Should Watch Out
at Seeking Alpha - Mon 2:22 pm ET
·Allergan: Take That Valeant Pharmaceuticals!
at - Mon 2:21 pm ET
·Allergan Stock Earnings: Good Enough to Fight off Valeant?
at Motley Fool - Mon 2:09 pm ET
·Ackman says Valeant-Allergan deal looks closer-CNBC
Reuters - Mon 1:11 pm ET
·Video: Allergan Earnings, Job Cuts Counter Valeant
at Investor's Business Daily, Inc. - Mon 12:37 pm ET
·[video] Allergan Plays Defense Against Valeant
at Bloomberg - Mon 12:35 pm ET
·[video] Ackman: Will not raise offer for Allergan
at CNBC - Mon 12:31 pm ET
·[video] Big pharma battle escalates
at CNBC - Mon 12:30 pm ET
·[video] U.S. Charges Russia With Hiding Evidence in MH17 Downing
at MarketWatch - Mon 11:59 am ET
·Allergan results turn up the heat on Valeant
at MarketWatch - Mon 11:35 am ET
More Latest News...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
Clinical Trial Initiation
Accelerate clinical trial start-up, site selection, and recruitment.
Top Industries up to -75%
Top Top Industries at great prices! Save up to 75% on Top Industries.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Other Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?